Introduction
showed that Rudhira associates with MTs at sites often overlapping with Vimentin IFs suggesting that 143 these interactions may be regulated by local factors or Tubulin or Vimentin properties ( Figure 1E and 144 line profile). These data indicate that Rudhira may simultaneously associate with MTs and IFs and IF 145 association of Rudhira may favour its binding to MTs. 146 147 In agreement with its proposed role of bridging cytoskeletal components, we observed high overlap of 148 Rudhira with the known cytolinker protein Plectin ( Figure 1F ). PLA between Rudhira and Plectin 149 confirmed their interaction and suggested that they may have similar function in vivo ( Figure 1F' ). 150
Expectedly, MT-IF association in vivo was dramatically reduced in Rudhira depleted cells, as detected by 151 double immunofluorescence ( Figure 1G ) and confirmed by PLA ( Figure 1H ). Thus, Rudhira is critical for 152
MT-IF bridging in ECs. 153 154

Rudhira governs the association and dynamics of microtubules and Vimentin intermediate filaments 155 in endothelial cells 156
The crosstalk between IFs and MTs is essential for efficient EC migration [7, 15] . Hence, we tested for 157 the association of IFs and MTs in live cells in low density cultures, where cells are in a migratory state. 158
Live imaging of MTs using Silico-Rhodamine conjugated Docetaxel (SiR-Tubulin) showed that MTs grew 159 radially towards the cell periphery and were stabilized there in control cells (NS), whereas KD had fewer 160
MTs at the cell periphery and they often started to bend before reaching the periphery (red asterisk in 161 Figure S1A and Video S1). To test MT-IF crosstalk we transiently expressed Vimentin-GFP and incubated 162 cells with SiR-Tubulin. Like the endogenous Vimentin ( Figure 1A , G), Vimentin-GFP filaments were less 163 extended in KD cells, resulting in reduced alignment with MTs and perturbed dynamics ( Figure 2A and 164 Video S2). These data suggest that Rudhira is required for cytoskeletal crosstalk and organization for cell 165 migration. Rudhira may also have a role in promoting the assembly of or stabilizing IFs. 166
167
The MT cytoskeleton is a highly dynamic macromolecular assembly, with a turnover rate of 5-15 min. 168
MTs govern cell polarity and along with actin also control IF organization during migration. Controlled 169 MT dynamics and stability contribute to cell migration by release of cell-ECM contacts and polarized 170 asymmetric distribution of vesicles. Consistent with the earlier observation ( Figure 1A To test whether impaired migration of KD cells is due to defects in MT growth, we assessed EB1-GFP 178 transfected control and KD cells by live imaging. Rudhira-depleted cells had fewer EB1-GFP positive MTs 179 ( Figure 2C and Video S3). +TIPs bind to and stabilize MTs at FAs for a time period of more than 15 s. The 180 EB1 comets in KD cells appeared to be smaller in size and shorter-lived than those in control cells (Figure  181 2B, C, D and Video S3). Time-projected (for 60 s) images (see Methods) also showed that MT growth in 182 KD cells followed a criss-cross pattern towards the cell periphery, as compared to the straight linear 183 growth of MTs in control, as judged by EB1-GFP movement in live cells (Figure 2C, D and Video S4) . 184
Unlike MTs in controls which grew radially towards and were stabilized at the periphery, MTs in KD cells 185 were rarely stabilized and often started to bend before reaching the cell periphery. (Figure 2D and Video 186 S3, S4). This suggests that MTs in KD cells encounter a physical constraint, likely thick actin stress fibres 187 ( Figure 1B) , which may prevent their growth to the periphery, the site of cell-matrix adhesions. 188
189
Rudhira associates with and stabilizes microtubules 190
The differential association and dissociation of Microtubule-associated Proteins (MAPs) MTs are oriented towards the leading edge of a migrating cell and due to their higher affinity for MT 197 motors in vitro are considered to maintain directional migration by polarized delivery of vesicles [19] . 198
Immunolocalization for acetylated (Ac) tubulin in a scratched EC monolayer 2 h after wounding, showed 199 that compared to control, KD cells had fewer stable MTs that did not reach the leading edge ( Figure 3A) . 200
Immunoblot also showed significant decrease in Ac-and Glu-α-tubulin levels, indicating that Rudhira 201 depletion destabilized MTs ( Figure 3B ). This was confirmed by treatment with MT-depolymerising drug 202 and cold treatment. As compared to controls, MTs in Rudhira-depleted cells were more sensitive to both 203 MT depolymerization stresses ( Figure 3C , C'). 10 µM Nocodazole caused complete MT depolymerization 204 in both control and KD cells. However low concentrations of Nocodazole (4 nM to 400 nM) depolymerise 205 dynamic but not stable MTs in a dose-dependent manner. KD cells were more sensitive to 10 nM 206
Nocodazole and showed a dramatic reduction in MT number as compared to controls, which showed a 207 well-organized MT-array with little apparent reduction in MT numbers ( Figure 3C ). 208
209
Treatment of cells that overexpress Rudhira with MT-depolymerising doses of Nocodazole showed that 210 their MTs are Nocodazole-resistant, as compared to control, where most MTs were depolymerised 211 ( Figure 3D , S1B). Further, Glu-tubulin levels were increased ( Figure 3E ) and the stable MTs were often 212 associated with Rudhira as seen by immunolocalization ( Figure S1C ). Triple immunofluorescence analysis 213
showed that Rudhira had a preferential association with detyrosinated MTs ( Figure 3F and Figure 1A, B) . Expectedly, the bent and unaligned MTs in KD cells were unable 226 to reach FAs as compared to the controls, which efficiently targeted FAs radially ( Figure 4A showed that the levels of Vinculin and Paxillin were not significantly altered ( Figure 4C ). Conversely, 232
Rudhira overexpression increases migration rate [11] , and as expected, immunolocalization analysis 233 showed a mild decrease in FA size in Rudhira overexpressing cells (Rudh2AGFP) as compared to the 234 untransfected or vector controls ( Figure S2C ). Further, transient overexpression of Rudhira in KD cells 235 rescued the FA size phenotype ( Figure 4D ). Therefore, we hypothesized that Rudhira depletion may 236 increase FA assembly, or decrease disassembly or both. Double-immuno-localization showed that 237 Rudhira does not co-localize with Paxillin or pY ( Figure S2D Analysis Server, see Methods) [21] showed that FA assembly was not affected upon Rudhira depletion, 248 while disassembly was reduced to half of that in the control cells ( Figure 4E and Video S5). Time-249 projection of the live images also showed highly dynamic FAs in control cells, while KD FAs appeared to 250 be immobile ( Figure 4F and Video S5). 251
252
To confirm these results, we used specialized molecular and cellular functional assays. Rudhira-depleted 253 cells did not show significant difference in attachment but spread earlier than controls on fibronectin 254 matrix, indicating that FA assembly is not impaired ( Figure 4G Further, cortical actin bundles and stress fibres were dramatically reduced ( Figure 5A '). MTs did not 280 bend and could reach the cell periphery, possibly because they were not impeded by the thick cortical 281 actin ( Figure 5A inset, A'). These data suggest that the primary function of Rudhira is to provide 282 physiological stability to MTs, and the loss of Rudhira can be compensated for by stabilizing MTs or 283 inhibiting MT disassembly pharmacologically. However, MTs may also reorganize in response to ROCKi-284 induced cell shape changes, which cannot be ruled out. It is also possible that Rudhira depletion 285 deregulates Rho GTPase effectors like mDia and Tau, to affect MT stability. 286
287
To dissect the effect of Rudhira depletion on MT stability from other properties leading to defective FA 288 turnover, like cell shape changes, we transiently stabilized MTs in KD cells with Paclitaxel and scored for 289 FA size. We observed a dose-dependent decrease in FA size with increasing concentration of Paclitaxel 290 (Taxol, 10 nM to 100 nM) ( Figure 5B ). This suggests that drug-mediated MT stabilization can partially 291 rescue the FA phenotype resulting from loss of Rudhira. However, at higher concentrations of Paclitaxel, 292 FA size increased again, possibly due to drastic loss of MT dynamics, which could impede FA turnover. 293
More interestingly, transient treatment with either ROCKi or Taxol led to the reorganization of Vimentin 294
IFs and their co-association with MTs in KD cells ( Figure 5C ). Importantly, all concentrations of Taxol (10 295 nM to 500 nM) resulted in the extension of Vimentin IFs and their association with MTs. These data 296 indicate that pharmacologically stabilizing MTs while still maintaining their dynamics in Rudhira depleted 297 cells is sufficient to restore normal cytoskeletal organization. These data suggest that the primary role of 298 Figure 5D ). This suggests that Rudhira is essential for MT stability, cytoskeletal crosslinking, 313 organization and dynamics during developmental vascular remodeling. 314
315
The C-terminal BCAS3 domain is necessary and sufficient for cytoskeletal organization and cell 316
migration. 317
To elucidate how the organization of Rudhira protein mediates its function, we undertook a deletion 318 analysis. Rudhira is reported to have predicted WD40-like structural domains, involved in protein 319 interactions, at the N-terminal region and an uncharacterized BCAS3 domain in the C-terminal region 320
[24]. Using multiple bioinformatics domain analysis servers and based on high confidence score we 321 mapped the limits of these domains ( Figure S4A , also see Methods). Rudhira also encodes multiple 322 isoforms, and a shorter isoform of unknown function that lacks the initial 229 residues is reported. 323
Protein structure prediction tool Phyre2 predicted one β-propeller (maximum 99.8% confidence and 324 17% identity) near the N-terminus (residues 92-434) ( Figure S4B ) and RaptorX predicted the presence of 325 two β-propellers (residues 57-350, 351-582) ( Figure S4B') . Interestingly, the C-terminal region did not 326 align to any structure and is considered to be highly disordered ( Figure S4B , B'). A PEST motif (signal for 327 protein degradation, residues 883-903) was also identified in the C-terminal region ( Figure 6A, S4A) . 328
329
While the WD40 domains function in protein-protein interactions, the BCAS3 domain is reported in 330 proteins expressed in breast cancer and implicated in the progression of breast cancer [25] . 331
Interestingly, a majority of the Rudhira post-translational modifications (PTMs) identified in high-332 throughput mass spectrometric screens were present in the C-terminal half of the protein (BCAS3+ 333 fragment), which houses the BCAS3 domain, typically 229-245 amino acids long ( Figure S4C showed putative MT-interacting motifs in Rudhira distributed along the entire length of the protein 336 ( Figure S4D ). Structural prediction using RaptorX suggested that while the N-terminal 1-460 fragment 337 containing WD40 domains would form a 6-bladed β-propeller and ∆BCAS3 (∆522-805) would form two 338 β-propellers as in the full-length protein, the BCAS3+ fragment (461-928) would be mostly disordered 339 ( Figure S4E ). Based on this information, we generated deletion mutants harbouring/lacking the putative 340 domains or isoforms ( Figure 6A ) (see Methods) and expressed them in HEK293T cells. 341 342 Some of the deletion mutants expressed poorly, suggesting that the fragments may be unstable. 343
Treatment with the proteasomal inhibitor MG132 stabilized these fragments ( Figure 6B ). However, the 344 WD40 domain containing fragment devoid of the BCAS3 domain (∆BCAS3), and the BCAS3 domain 345 containing fragment (BCAS3+), both expressed at levels similar to those of the full-length protein (Full) . 346 Also, the WD40 and the BCAS3 domains were predicted at high confidence by multiple bioinformatics 347 tools, as compared to other domains/motifs ( Figure S4A ). Hence further molecular and functional 348 analysis was limited to these to avoid the possible differences due to varied expression levels. and fewer growing MTs in KD cells suggest a role for Rudhira before MTs encounter actin stress fibres at 426 the cell periphery. Rudhira-mediated control of FA and MT dynamics are unlikely to be independent, 427 owing to the strong correlation between the organization of the two as suggested in the literature as 428 well as in our study [10] . 429 430 MT-growth initiates primarily from the MT organizing centres (MTOCs). Loss of, or structural defects in 431 the MTOCs, which are primarily centrosomes in endothelial cells, may also explain the defects in MT 432 growth and stability. However, earlier studies suggest that although the MTOC does not realign along 433 the direction of migration, it is indeed present in rudhira KD cells [11] . The contribution from the defects 434 in polarity caused by Rudhira depletion may also lead to disorganized MT growth and architecture [11] . 435
Additionally, the involvement of independent molecular pathways controlling FA and MT organization 436 cannot be ignored. Identification of further molecular interactors of Rudhira will delineate its position in 437 the molecular pathway governing MT growth and recruitment to FAs. Bioinformatics analysis reveals the 438 presence of SxIP motifs towards the C terminus of Rudhira, suggesting an interaction with EB proteins 439 [29] . Thus, Rudhira may have a prominent role in MT growth towards FAs via EB proteins, known to be 440 essential for MT growth and polarity. This also raises the interesting possibility that Rudhira may lay 441 down tracks for MT growth. 442
443
The Rudhira protein has several conserved domains such as WD40 domains and the BCAS3 domain, 444 however the relevance of its organization in the normal in vivo function of Rudhira is not known. WD40 445 domain-containing proteins assume a beta propeller structure that is thought to act as a scaffold for 446 multiple protein interactions. However, our experiments suggest that the C terminal fragment bearing 447 the BCAS3 domain, rather than the N-terminal WD40 domain containing fragment, could bind tubulin 448 and importantly, restore function. In addition to the BCAS3 domain, the BCAS3+ fragment includes a 449 PEST domain, SxIP motifs, some of the C-terminal region and frequently reported phosphorylation sites, 450 which may also contribute to the function. However, these additional features require the BCAS3 451 domain, as removing the BCAS3 alone caused loss of BCAS3+ function. Some of the fragments, including 452 the alternative isoform, the PEST motif deletion and others, showed increased susceptibility to 453 ubiquitin-proteasome mediated degradation, suggesting complex regulation. It is possible that some of 454 these, like the alternative isoform, could be transiently and dynamically expressed for temporal control 455 of Rudhira function, a possibility that merits further investigation. It is likely that this isoform has a 456 physiologically relevant role, which enhances Rudhira function in specific contexts, as it contains the 457 conserved BCAS3 domain but lacks the WD40 or other domains. This report also assigns molecular 458 function to the conserved BCAS3 domain sequence. It will be interesting to test whether the BCAS3 459 domains present in many autophagy-related proteins and proteins expressed in cancers share similar 460 Cycloheximide, ROCK inhibitor (ROCKi, Y27632) and Taxol (Paclitaxel) were from Sigma Chemical Co., 500
USA. NS and KD cells were treated with 50 µg/ml of Cycloheximide for a period of 0, 7 and 14 h. 501
Thereafter, the cells were taken for immunoblot analysis ( Figure S3C ). Cells were treated with ROCKi or 502
Taxol for 1 h and processed for immunostaining with Paxillin, Tubulin or Vimentin antibodies or 503 Phalloidin, as indicated ( Figure 5A, B, C) . software from Zeiss. Super-resolution microscopy was performed by imaging in the Airy Scan image 512 acquisition and processing mode of the LSM 880, Zeiss. For live cell imaging, a sample heater (37°C) and 513 CO 2 incubation chamber (Tokai Hit) were used to control temperature and CO 2 levels during live cell 514 imaging. All images in a set were adjusted equally for brightness and contrast using Adobe Photoshop 515 CS2, where required. Rudhira NS or KD cells were transiently transfected with EB1-GFP and seeded on 516 fibronectin-coated glass-bottom dishes. Live imaging for EB1-GFP was carried out 24 h post seeding for 3 517 min at 4 s intervals to determine MT growth and alignment. EB1-GFP live images were time-projected in 518
ImageJ (NIH) to represent MT growth. EB1-GFP tracks were generated manually and residence time was 519 calculated manually using ImageJ (NIH) with the manual tracking plug-in. Rudhira NS or KD cells were 520 transiently transfected with Paxillin-GFP and seeded on fibronectin-coated glass-bottom dishes. Live 521 imaging for Paxillin-GFP was carried out 24 h post seeding for 2-3 h at 5 min intervals to determine FA 522 assembly and disassembly rates under steady state. The images were processed for estimation of 523 various parameters using Focal Adhesion Analysis Server (FAAS) [21] . Paxillin-GFP, EB1-GFP live images 524
were time-projected in ImageJ (NIH) to represent FA and MT growth dynamics respectively. Rudhira NS 525 or KD cells were transiently transfected with Vimentin-GFP and seeded on fibronectin-coated glass-526 bottom dishes. Cells were incubated with 250 nM SiR-Tubulin for 2 hours before live imaging was carried 527 out for 4 min at 10 s intervals to test coalignment of MTs and IFs. 528
530
In situ Proximity Ligation Assay (PLA or Duolink assay) 531
In situ PLA (Proximity Ligation Assay) reaction was performed on SVEC cell lines. The cells were cultured, 532 fixed, permeabilised and stained with primary antibodies as indicated. Thereafter, the protocol for PLA 533 as recommended by manufacturer (Duolink, USA) was followed. Post PLA, nuclei were counterstained 534 with DAPI. 535 536
Cell attachment and spreading assays 537
The assays and quantitation were carried out as mentioned in [30] which has cited [31] , with a few 538 modifications. Briefly, 96-well plates were coated with fibronectin (10 µg/ml) for 60 min at room 539 temperature and blocked with heat-denatured filter-sterilized BSA for 30 min at room temperature. 540
Cells were put in suspension in warm medium at 37 ˚C, 5% CO 2 to disassemble already formed FA. 541 Thereafter, 20000 (for attachment) or 10000 (for spreading) cells were seeded per well and allowed to 542 attach or spread for the indicated times. Floating or loosely attached cells were removed by washing 543 twice with PBS and then fixed with 4% paraformaldehyde. For spreading assay, the extent of spreading 544 was quantified in ImageJ (NIH) from RFP (expressed from the NS or KD vector) images. For attachment 545 assay, cells were stained with 0.1% crystal violet for 60 min at room temperature, washed three times 546 with water and the dye was solubilised in 100 µl 10% acetic acid and the absorbance was measured at 547 570 nm using a plate reader. The total number of cells attached at 3 h was set to 100% for both NS and 548 KD lines. onto the upper chamber of the transwell filter inserts with 8 μm pore size, 24-well format (Costar, USA). 585 10% serum medium was added to the lower chamber to serve as a chemo-attractant. After 24 h, cells 586 were fixed in 4% paraformaldehyde for 10 min at room temperature. Cells on the top of the filter were 587 removed using a cotton swab. Cells that had migrated to the bottom were fixed and stained with 0.5% 588 crystal violet for 10 min at room temperature. Figure 2D, S2C) , pCMV-RudhFL-FLAG were described 606 earlier [11] . Rudhira ORF was sub-cloned from pCAG-Rudh-2A-GFP vector into pEGFP-N3 vector 607 (Clontech, USA) using NheI-SacII sites to obtain pCAG-Rudhira-GFP ( Figure 3D, S4A, B) . For deletion 608 mutant cloning, the regions to be cloned were PCR amplified from pCMV-RudhFL-FLAG vector and 609 cloned in pCMV-Tag2B vector (Stratagene, USA) ( Figure 5B, C) . The desired fragments from pCMV-Tag2B 610 vectors were digested using EcoRI-XhoI and sub-cloned into the compatible EcoRI-SalI sites of pIRES2-611 EGFP vector (Clontech), to obtain GFP fluorescent reporter plasmids ( Figure 3E , 5D, E, F, S5F, G). EB1-612 GFP plasmid was a kind gift from Yuko Mimori-Kiyosue (Riken Kobe, Japan) and Paxillin-GFP was a kind 613 gift from Rick Horwitz. HEK293 and HEK293T cells were transfected using Calcium Phosphate method 614 and SVEC cells were transfected using Lipofectamine 2000 (ThermoFisher Scientific, USA). based on putative motifs/domains identified using bioinformatics analyses (see Methods). WD1, WD2: 733
